References
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun M J. Cancer Statistics, 2006. Cancer J Clin 2006; 56: 106–130
- Acker B, Hoppe R T, Colby T V, Cox R S, Kaplan H S, Rosenber S A. Histologic Conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1982; 1: 11–16
- Uranues S, Alimoglu A. Laparoscopic surgery of the spleen. Surg Clin N Am 2005; 85: 75–90
- Poulin E C, Schlachta C M, Mamazza J. Laparoscopic splenectomy. Operative Techn Gen Surg 2004; 6: 42–54
- Horowitz J, Smith J L, Weber T K, Rodriguez-Bigas M A, Petrelli N J. Postoperative complications after splenectomy for hematologic malignancies. Ann Surg 1996; 223: 290–296
- Donini A, Baccarani U, Terrosu G, Corno V, Ermacora A, Pasqualucci A, et al. Laparoscopic versus open splenectomy in the management of hematologic diseases. Surg Endosc 1999; 13: 1220–1225
- Walsh R M, Brody F, Brown N. Laparoscopic splenectomy for lymphoproliferative disease. Surg Endosc 2004; 18: 272–275
- Vakra A K, Sweeney J F. Laparoscopic splenectomy: a review. J Long-Term Effects Med Implants 2004; 14: 347–358
- Haioun C, Itti E, Rahmouni A, Brice P, Rain J D, Belhadj K, et al. [18]F-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005; 106: 1376–1381
- Schöder H, Noy A, Gönen M, Weng L, Green D, Erdi Y E, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol 2005; 23: 4643–4651
- Karam M, Novak L, Cyriac J, Ali A, Nazeer T, Nugent F. Role of fluorine-18 deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer 2006; 107: 17–83
- Rini J N, Leonidas J C, Tomas M B, Palestro C J. 18-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med 2003; 44: 1072–1074
- Elstrom R, Guan L, Baker G, Nakhoda K, Vergilio J A, Zhuang H, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003; 101: 3875–3876
- Tsukamoto N, Kojima M, Hasegawa M, Oriuchi N, Matsushima T, Yokohama A, et al. The usefulness of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) and a comparison of 18F-FDG-pet with 67gallium scintigraphy in the evaluation of lymphoma. Cancer 2007; 110: 652–659
- Juweid M E, Stroobants S, Hoekstra O S, Mottaghy F M, Dietlein M, Guermazi A, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of International Harmonization Project in lymphoma. J Clin Oncol 2007; 26: 571–578